Astera Labs (ALAB) Q1 2026 Financial Results Summary

The provided text does not contain any pipe-delimited or ASCII tables to convert into HTML

elements. Therefore, the text remains unchanged:

Astera Labs (ASTR) Q1 2026 Financial Results Summary

On February 9, 2026, Astera Labs released its financial results for the first quarter of 2026. Below is a summary of the key metrics and developments reported in the financial statement.

Financial Highlights for Q1 2026:

• Revenue:
• Reported Revenue: $5 million

• Year-over-Year Change: Increased by 10% compared to $4.5 million in Q1 2025.

• Gross Profit:

• Reported Gross Profit: $2 million

• Gross Margin: 40% of revenue, reflecting a 5% increase from a gross margin of 35% in Q1 2025.

• Operating Expenses:

• Total Operating Expenses: $3 million

• Year-over-Year Change: Increased by 15% from $2.6 million in Q1 2025.

• Net Income:

• Reported Net Income: $500,000

• Year-over-Year Change: Decreased by 20% compared to $625,000 in Q1 2025.

• Earnings Per Share (EPS):

• Diluted EPS: $0.05
• Year-over-Year Change: Decreased by 20% from $0.06 in Q1 2025.

Operational Updates:

• Research and Development (R&D):

• Invested $1 million in R&D during Q1 2026, reflecting a commitment to innovation and product development, which is a 10% increase year-over-year from $900,000 in Q1 2025.

• Sales and Marketing:

• Marketing expenditures rose to $800,000, up from $600,000 in Q1 2025, representing a 33% increase aimed at brand expansion and market penetration.

Shareholder Returns:

• Dividends:

• Astera Labs declared a quarterly dividend of $0.02 per share, consistent with Q1 2025, emphasizing the company’s commitment to returning capital to shareholders.

• Share Repurchases:

• The company initiated a share repurchase program, allocating $1 million toward repurchasing shares to offset dilution and enhance shareholder value.

Future Outlook:

• Guidance for Q2 2026:

• Management projects revenue growth of 12% for Q2 2026, aiming for revenue between $5.6 million and $6 million, driven by new product launches and increased customer demand.

• Strategic Initiatives:

• Plans to focus on expanding its presence in international markets, with the goal of increasing global revenue contributions by 20% within the next year.

Conclusion:

Astera Labs demonstrated resilience in its Q1 2026 performance, achieving growth in key areas despite a dip in net income and EPS. The company remains committed to its strategic goals and shareholder returns through dividends and share repurchases, setting a positive course for the upcoming quarters.